Cost analysis of three intravenous drug delivery systems in a neonatal intensive care unit

Am J Health Syst Pharm. 1996 Oct 1;53(19):2314-8. doi: 10.1093/ajhp/53.19.2314.

Authors

Y K Yu¹, D Y Ishisaka, T T Nishizaki, A M Lee-Ow, F C Oliver

Affiliation

¹ Department of Pharmacy, Lucile Salter Packard Children's Hospital at Stanford, Palo Alto, CA 94304, USA.

PMID: 8893071
DOI: 10.1093/ajhp/53.19.2314

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / administration & dosage*
Costs and Cost Analysis
Drug Compounding
Drug Delivery Systems / economics*
Humans
Infant, Newborn
Injections, Intravenous / instrumentation*
Intensive Care, Neonatal
Pharmacy Service, Hospital

Substances

Anti-Bacterial Agents